Navigation Links
YM BioSciences Announces Data from Nimotuzumab Phase II Gastric Cancer Trial Reported at ASCO GI Symposium
Date:1/20/2011

cted six months after completion of randomization with a median follow-up period of 197 days.

The primary endpoint was PFS (Progression Free Survival) and the secondary endpoints included safety, ORR (Overall Response Rate), OS (Overall Survival), and PK. Eighty-two eligible patients (ECOG PS 0-1, one prior regimen) were treated with N+I (n = 40) or I (n = 42). Tumor tissues collected from 48 patients (N+I arm: 26, I arm: 22) were analyzed for EGFR and K-ras. EGFR status (0/1+/2+/3+) examined by immunohistochemistry was 44%/25%/13%/17% respectively.

Results: - Median PFS was 73.0 days in the N+I arm compared with 85.0 days in the I arm (HR 0.860; 95% CI, 0.516, 1.435). - Overall Survival was 293.0 days in the N+I arm compared with 227.0 days in the I arm among 82 patients (HR 0.717; 95% CI, 0.420, 1.224). - In the subgroup analyses, the hazard ratio in PFS for patients with EGFR 1+/2+/3+ was 0.463 (95%CI, 0.177, 1.212) and that of EGFR 2+/3+ was 0.341 (95% CI, 0.080, 1.457) and the hazard ratio in OS was 0.584 (95% CI, 0.242, 1.409) and 0.295 (95% CI, 0.077, 1.129), respectively. - The incidence of adverse events was similar between both arms. - No adverse events of grade 3 skin rash or grade 3 infusion-related reactions were reported.

About nimotuzumab:

Nimotuzumab is a humanized monoclonal antibody in development worldwide, targeting multiple tumor types primarily in combination with radiation and chemoradiation. It is importantly differentiated from other currently marketed EGFR-targeting agents due to its enhanced side-effect profile. Nimotuzumab's anti-tumor activity has led to its approval for marketing in 25 countries. In more than 10,000 patients reported as having been treated with nimotuzumab worldwide to date, Grade IV incidents of radiation dermatitis and incidents of severe rash have been only rarely observed, and reports of the other severe side-effects that are typical of EGFR-targeting molecules have been equally rare.
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
2. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
3. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
4. Milestone Biosciences, LLC Further Strengthens Executive Management Team
5. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
6. Access Pharmaceuticals Licenses MuGard to Milestone Biosciences, LLC for North America
7. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
8. Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference
9. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
10. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium
11. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... NY (PRWEB) June 18, 2013 In ... and sustainability, the Consulate General of Switzerland in New ... boat, Switzerland’s MS Tûranor PlanetSolar , to Manhattan. ... of its DeepWater Expedition 2013 tour with scientists on ... by Capitain Gérard d’Aboville, runs exclusively on energy from ...
(Date:6/18/2013)... Demanding industrial and environmental conditions are no ... and Glass Ball Lenses, now available in an extensive ... , of Philadelphia , PA. , Optical Ball Lenses ... beams without the need for direct physical contact. That’s ... mohs) make it the ideal choice for fiber-optic applications ...
(Date:6/18/2013)... AZ (PRWEB) June 18, 2013 Nasseo, ... 2013 Innovation Challenge Winner out of hundreds of applicants ... its spring Arizona Innovation Challenge . The Arizona ... country for a technology commercialization challenge, granting a financial ... most promising technology ventures. Nasseo’s state of the art ...
(Date:6/18/2013)... ATLANTA , June 18, 2013  regulated information ... Jeff Klauk today announced the launch of ... their loved ones. The Pledge ... take a stand and make a personal commitment to ... with their health care team and additional partial-onset seizure ...
Breaking Biology Technology:Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6
... 31 China Agro-Technology,Holdings Ltd ("CAT") today announced that ... Executive Officer, replacing interim CEO Harry,He, effective as of ... York., CAT is a leading agro-biotechnology company listed ... company reported total audited revenues of,US$37 million in fiscal ...
... DIEGO, Jan. 31 /PRNewswire-FirstCall/ - MIGENIX Inc.,(TSX: MGI, ... infectious,diseases, will add a 600mg celgosivir combination therapy ... study in hepatitis C virus,("HCV") treatment-naive patients. The ... and Institutional Review Board (IRB) approvals. The,purpose of ...
... Research Initiatives in Search of a Cure and Therapies ... ... 31 The Christopher and Dana,Reeve Foundation (CDRF), which is dedicated ... quality of life for people,living with paralysis through grants, information and ...
Cached Biology Technology:China Agro-Technology Appoints New CEO 2China Agro-Technology Appoints New CEO 3MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 2MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 3MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 4MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 5MIGENIX to Add 600mg Daily Celgosivir Dose to Phase II Viral Kinetics Study 6Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 2Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 3
(Date:6/19/2013)... world-leading provider of scientific, technical and medical information products ... a new open access journal, GeoResJ . ... earth and planetary science journals portfolio has its first ... a forum for rapid publication of top research within ... co-edited by six Executive Editors, each covering a different ...
(Date:6/18/2013)... not a hacker lab. At Brandeis University, sophisticated ... are helping scientists understand the complex interplay between ... the virus, outer "shell" critical for replication. ... what we are finding will help researchers alter ... post-doctoral fellow Jason Perlmutter, first author of the ...
(Date:6/18/2013)... 18, 2013: The Association for Molecular Pathology is proud ... Societies for Experimental Biology (FASEB) on July 1, 2013. ... June 3, 2013. , The 26 constituent societies ... a common vision for the advancement of research and ... translational research is more important now than ever," said ...
Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2
... have discovered a new source of stems cells and ... vessel, nerve and liver cells in the laboratory. The ... cells from the amniotic fluid that surrounds developing embryos ... is that these cells will provide a valuable resource ...
... Immune cells that are the body’s front-line defense don’t ... on their outside skins and rouse them to action, ... Michigan scientists describe their findings that bacteria can barge ... immune response. , The study, published online ahead ...
... ocean circulation and sea levels in the centuries to come? ... zones in the oceans on the rise? Can aquaculture be ... the collapse of coastal fisheries? , Most importantly, what can ... of the news media are invited to join leading international ...
Cached Biology News:Scientists discover new, readily available source of stem cells 2Scientists discover new, readily available source of stem cells 3Microbes start immune response by sneaking inside cells 2Are we killing the world's oceans? 2